Replacement of Principal Investigator. In the event that the Principal Investigator is unwilling or unable to perform his or her duties hereunder, Licensor shall promptly appoint a successor mutually agreeable to the parties.
Appears in 4 contracts
Samples: License Agreement (Peptide Therapeutics Group PLC), License Agreement (Peptide Therapeutics Group PLC), License Agreement (Oravax Inc /De/)